MX2009003930A - Novedoso cristal de (s)-(+)-2-(2-clorofenil)-2-hidroxi-etil carbamato. - Google Patents

Novedoso cristal de (s)-(+)-2-(2-clorofenil)-2-hidroxi-etil carbamato.

Info

Publication number
MX2009003930A
MX2009003930A MX2009003930A MX2009003930A MX2009003930A MX 2009003930 A MX2009003930 A MX 2009003930A MX 2009003930 A MX2009003930 A MX 2009003930A MX 2009003930 A MX2009003930 A MX 2009003930A MX 2009003930 A MX2009003930 A MX 2009003930A
Authority
MX
Mexico
Prior art keywords
chlorophenyl
hydroxy
ethyl carbamate
crystal
novel crystal
Prior art date
Application number
MX2009003930A
Other languages
English (en)
Inventor
Michael Tauber
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2009003930A publication Critical patent/MX2009003930A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/08—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton

Abstract

La presente invención se refiere a un novedoso cristal del Ingrediente Farmacéutico Activo (API) (S)-(+)-2-(2-clorofenil)-2-h idroxi-etil carbamato, métodos para la preparación de este cristal, composiciones farmacéuticas que comprenden este cristal, y métodos para tratar a un paciente con este cristal.
MX2009003930A 2006-10-10 2007-10-05 Novedoso cristal de (s)-(+)-2-(2-clorofenil)-2-hidroxi-etil carbamato. MX2009003930A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82878506P 2006-10-10 2006-10-10
PCT/US2007/021423 WO2008063284A2 (en) 2006-10-10 2007-10-05 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate

Publications (1)

Publication Number Publication Date
MX2009003930A true MX2009003930A (es) 2009-04-23

Family

ID=39430239

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003930A MX2009003930A (es) 2006-10-10 2007-10-05 Novedoso cristal de (s)-(+)-2-(2-clorofenil)-2-hidroxi-etil carbamato.

Country Status (13)

Country Link
US (1) US20080194860A1 (es)
EP (1) EP2076135A2 (es)
JP (1) JP2010505952A (es)
KR (1) KR20090082209A (es)
AU (1) AU2007322339A1 (es)
BR (1) BRPI0717824A2 (es)
CA (1) CA2666159A1 (es)
CO (1) CO6210773A2 (es)
EA (1) EA200970368A1 (es)
IL (1) IL198114A0 (es)
MX (1) MX2009003930A (es)
NO (1) NO20091629L (es)
WO (1) WO2008063284A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN103523248B (zh) * 2013-09-26 2017-03-08 黎明 一种棉产品包装装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69112917T2 (de) * 1990-06-15 1996-05-15 Merck & Co Inc Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
WO2000028991A1 (fr) * 1998-11-13 2000-05-25 Fujisawa Pharmaceutical Co., Ltd. Remedes contre le syndrome des ovaires polykystiques
CA2416819C (en) * 2000-07-21 2011-03-22 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
WO2004078163A2 (en) * 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen

Also Published As

Publication number Publication date
JP2010505952A (ja) 2010-02-25
EA200970368A1 (ru) 2009-10-30
AU2007322339A1 (en) 2008-05-29
BRPI0717824A2 (pt) 2014-04-15
IL198114A0 (en) 2009-12-24
WO2008063284A2 (en) 2008-05-29
US20080194860A1 (en) 2008-08-14
KR20090082209A (ko) 2009-07-29
NO20091629L (no) 2009-05-06
WO2008063284A3 (en) 2008-07-10
CA2666159A1 (en) 2008-05-29
EP2076135A2 (en) 2009-07-08
CO6210773A2 (es) 2010-10-20

Similar Documents

Publication Publication Date Title
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
WO2007112000A3 (en) Treatment of pain
EA200870599A1 (ru) Стабильные препараты лаквинимода
MY148496A (en) Dpp iv inhibitor formulations
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
WO2012047587A3 (en) Mdm2 inhibitors for treatment of ocular conditions
MY143795A (en) Tetrahydropyridoindole derivatives
EP2349279A4 (en) ALDEHYDE DEHYDROGENASE MODULATORS AND METHOD OF USE THEREOF
EA200801997A1 (ru) Новые соединения
TW200639159A (en) Treatment of pain
TW200626553A (en) Novel compounds
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
DE502005005636D1 (en) Spirocyclische cyclohexan-derivate
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
WO2009032843A3 (en) Deuterated ethambutols and their use
WO2009019708A3 (en) Pharmaceutical compositions and methods for the treatment of cancer
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
WO2012002773A3 (en) Phenylcarbamate compound and muscle relaxant containing the same
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2006113718A3 (en) Compositions for the treatment of neoplasms
WO2005092878A3 (en) Schweinfurthin analogues

Legal Events

Date Code Title Description
FA Abandonment or withdrawal